Digital Pathology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Digital Pathology Market: By Product Type (Scanners, Software Solution/Application, Communication System, and Storage System), By Application (Research & Academics, Clinical Research & Toxicology, and Clinical (diagnostic, telepathology, etc.)), and Usage (Human Pathology and Animal Pathology), End-User (Hospitals, Reference Labs & Pathologists, Pharmaceutical Companies/CROs, Academic & Research Institutes, and Others (vets, clinics, etc.)) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The digital pathology market size is valued at USD 612.3 million in 2021, and it is predicted to increase at a CAGR of 12.7 percent from 2022 to 2028, reaching USD 1,03.5 million by 2028. Digital pathology is the practice of examining high-resolution digitally scanned histology images, which may subsequently be used with computer tools and algorithms. It is an image-based platform that allows pathology information to be acquired, managed, and interpreted from a digitized glass slide. Primary diagnosis, diagnostic consultation, intraoperative diagnosis, medical student and resident teaching, manual and semi-quantitative immunohistochemistry (IHC) evaluation, clinical research, diagnostic decision assistance, peer review, and tumor boards are all examples of healthcare uses. After the FDA authorized the first entire slide scanner for use in primary diagnosis in April 2017, the digital pathology market began to gather traction. Many pathology labs in the U.S. and Europe are switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. Scanners had a market worth of USD 387.5 million in 2021, and it is expected to expand at a substantial CAGR between 2022 and 2028. The large share of the scanners segment can be attributed to the high price of scanners, the increasing adoption of digital pathology solutions, increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. By Type segment, human pathology holds the market revenue share of 37.8% and it is estimated to grow with a significant CAGR from 2022 to 2028.

Recent Market Developments:

In May 2022, Digital pathology firm Indica Labs Nabs CE Mark for AI-Based Prostate Cancer Detection, Gleason Grading Tool.

In May 2022, Crosscope and Farcast Biosciences joined efforts to reshape the precision oncology landscape via AI-powered pathology.

Digital Pathology Market

MARKET SUMMARY
-
12.7%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.7%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Digital Pathology Market Analysis

  • The report on global digital pathology market gives historical growth, current trends, and future market sizes (US$ Mn) on the basis of product type, application, usage, end-user, and geography.
  • The digital pathology market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Market Leaders
  • Perkin Elmer Inc. (U.S.)
  • Spectra AB (Sweden)
  • DigiPath Corp (U.S.)
  • 3D-Histech Ltd (Hungary)
  • GE Healthcare (U.S.)
Digital Pathology Market

Drivers and Restraints

The rise in cancer prevalence, as well as the demand for accurate diagnostics, the rise in the geriatric population, and rapid technological advancements, are driving growth in the global digital pathology market. Moreover, the entry of established MedTech players into the digital pathology market is seen as a validation of the concept that the technology can transform the fact of pathology. However, the high cost of digital pathology systems is hampering the market growth. The cost of digital pathology hardware, such as scanners, is a significant obstacle to market growth. The introduction of low-cost scanners will encourage their adoption among pathologists with low or limited budgets.


Digital Pathology Market Regional Analysis

North America dominates the market

The digital pathology market in North America is expected to hold the highest share of 42.8% in 2021 and it is expected to grow at a significant rate in the coming years. The rising prevalence of cancer, rising demand for quality diagnostics, the implementation of favourable reimbursement policies, and the implementation of favourable initiatives by governments in the United States and Canada are major factors driving the growth of the digital pathology market in North America.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Recent Developments

Digital Pathology Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Perkin Elmer Inc. (U.S.)
  • Olympus Corporation (Japan)
  • Spectra AB (Sweden)
  • Philips Healthcare (U.S.)
  • Danaher Corporation (Leica Microsystems) (U.S.)
  • ZEISS Group (Germany)
  • Roche Diagnostics (Germany)
  • DigiPath Corp (U.S.)
  • 3D-Histech Ltd (Hungary)
  • GE Healthcare (U.S.)

Description

The digital pathology market size is valued at USD 612.3 million in 2021, and it is predicted to increase at a CAGR of 12.7 percent from 2022 to 2028, reaching USD 1,03.5 million by 2028. Digital pathology is the practice of examining high-resolution digitally scanned histology images, which may subsequently be used with computer tools and algorithms. It is an image-based platform that allows pathology information to be acquired, managed, and interpreted from a digitized glass slide. Primary diagnosis, diagnostic consultation, intraoperative diagnosis, medical student and resident teaching, manual and semi-quantitative immunohistochemistry (IHC) evaluation, clinical research, diagnostic decision assistance, peer review, and tumor boards are all examples of healthcare uses. After the FDA authorized the first entire slide scanner for use in primary diagnosis in April 2017, the digital pathology market began to gather traction. Many pathology labs in the U.S. and Europe are switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. Scanners had a market worth of USD 387.5 million in 2021, and it is expected to expand at a substantial CAGR between 2022 and 2028. The large share of the scanners segment can be attributed to the high price of scanners, the increasing adoption of digital pathology solutions, increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. By Type segment, human pathology holds the market revenue share of 37.8% and it is estimated to grow with a significant CAGR from 2022 to 2028.

Recent Market Developments:

In May 2022, Digital pathology firm Indica Labs Nabs CE Mark for AI-Based Prostate Cancer Detection, Gleason Grading Tool.

In May 2022, Crosscope and Farcast Biosciences joined efforts to reshape the precision oncology landscape via AI-powered pathology.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX